# LabelAI Phase 4 — Evidence-Grounded AI Label Authoring Evaluation

**Date:** 2026-10-13  
**Status:** Completed & Validated (59/59 automated tests passing)  
**System Version:** LabelAI Phase 4  
**Repository:** `C:\Users\soubhagy\Downloads\lable AI`  

---

## 1. Executive Summary & Objective

In Phase 4, LabelAI implemented an **AI-assisted, evidence-grounded label authoring module**. The system synthesizes approved product facts, existing approved label versions, change-impact assessments, and retrieved regulatory evidence to generate a proposed revised label with deterministic version comparison and traceable field-level human review.

### Key Tenets & Boundaries
- **Drafting & Review Tool Only:** LabelAI does not autonomously approve or certify medical-device labeling.
- **Strict Evidence Grounding:** Content is generated only where sufficient approved product information and retrieved regulatory evidence are present.
- **Zero Hallucination Policy:** The engine never fabricates clinical indications, contraindications, warnings, dimensions, UDI identifiers, or manufacturer addresses.
- **Explicit Limitations & Gaps:** Missing product facts and unindexed/paywalled standards (e.g. ISO 15223-1 symbols) are surfaced directly as `evidence_gap` limitations rather than guessed.
- **100% Deterministic Baseline:** Fully functional offline without external paid LLM APIs.

---

## 2. Structured Label Data Model

The label model (`LabelDocument`) represents medical device labeling across 14 standardized fields:

| Field Identifier | Field Label | Content Description |
| :--- | :--- | :--- |
| `product_name_identifier` | Product Name & Model / Catalog Number | Proprietary name, catalog/model numbers (REF), trade name |
| `manufacturer_info` | Manufacturer Name, Place of Business & Address | Legal manufacturer name, full street address, city, state, zip (21 CFR 801.1) |
| `intended_purpose` | Intended Purpose & Indications for Use | Target patient population, clinical condition, anatomical site (21 CFR 801.5) |
| `device_description` | Device Description & Technical Specifications | Physical specifications, materials, mechanism of action |
| `warnings_precautions` | Warnings, Precautions & Contraindications | Clinical risk statements, MRI safety, handling cautions |
| `instructions_for_use` | Instructions for Use (IFU) & Directions | Operating instructions, preparation, contraindication cross-references |
| `storage_handling` | Storage & Handling Conditions | Temperature limits, humidity, light sensitivity |
| `sterilization_info` | Sterilization Method & Sterile Barrier Status | Sterilization modality (EO, Gamma, Steam), sterile barrier integrity |
| `shelf_life_expiry` | Shelf-Life & Expiration Dating | Duration, expiration date format (YYYY-MM-DD) |
| `udi_identifiers` | UDI (DI + PI) & Machine-Readable Carrier | Human readable interpretation (HRI) + 2D DataMatrix / Linear barcode |
| `symbols_descriptions` | Graphical Symbols & Symbol Descriptions | Standardized symbols used (ISO 15223-1) and symbol legend |
| `target_jurisdiction` | Target Regulatory Jurisdiction | Applicable regulatory framework (e.g. US FDA 21 CFR, EU MDR, IMDRF) |
| `language` | Label Language(s) | Official language(s) of labeling |
| `label_version_status` | Label Version & Status | Version code (e.g. Rev C), document status, effective date |

---

## 3. Grounded Drafting Workflow

The authoring pipeline executes in 8 traceable steps:

1. **Input Validation:** Audits `approved_product_facts` and `existing_label` schemas; flags unsupported jurisdictions (e.g. Australia, India).
2. **Candidate Section Identification:** Maps `affected_label_elements` from the change-impact assessment to candidate label fields using `ELEMENT_TO_FIELDS_MAP`.
3. **Preservation of Unchanged Content:** All non-candidate fields are strictly preserved byte-for-byte from the previous approved label version.
4. **Regulatory Evidence Retrieval:** Queries `LocalTfidfRetriever` with jurisdiction filters (e.g. US FDA, IMDRF) or reuses attached assessment evidence.
5. **Grounded Field Authoring:**
   - Evaluates approved facts against regulatory requirements (e.g., 21 CFR 801.1 for manufacturer address, 21 CFR 801.40 for UDI).
   - If approved facts are present: drafts compliant label text citing the regulatory clause.
   - If approved facts are missing: preserves original text, marks field as `evidence_gap`, and flags missing information.
6. **Deterministic Version Diffing:** Compares original vs proposed values across all fields, classifying each as `added`, `removed`, `modified`, or `unchanged`.
7. **Traceability Logging:** Attaches evidence references (`EV001`, `EV002`), evidence state, and drafting rationale to every field.
8. **Human Review Routing:** Initializes review decisions to `Pending` (or `Accepted` for unchanged fields) and enforces mandatory regulatory sign-off.

---

## 4. Field-Level Version Comparison & Human Review

Every comparison generates a `VersionComparisonReport` tracking:
- `from_version` → `to_version`
- Counts of `modified_fields`, `unchanged_fields`, `added_fields`, `removed_fields`
- Field diffs with individual review status:
  - `Pending`: Initial draft awaiting review
  - `Accepted`: Qualified regulatory reviewer accepted proposed text
  - `Needs revision`: Reviewer requested modifications with notes
  - `Rejected`: Reviewer rejected change, reverting field to original approved text

---

## 5. Automated Validation & Test Suite

The test suite in `tests/test_label_authoring.py` verifies all requirements:

| Test Name | Focus | Result |
| :--- | :--- | :--- |
| `test_draft_generation_from_sufficient_approved_facts` | Manufacturer address change with complete Boston address facts | **PASS** |
| `test_missing_product_information` | Address change flagged, but street address missing in facts -> preserves original, flags gap | **PASS** |
| `test_unsupported_jurisdiction` | Australia market -> explicitly flags unindexed jurisdiction limitation | **PASS** |
| `test_insufficient_regulatory_evidence_for_symbols` | Symbol change -> flags ISO 15223-1 paywalled standard gap, does not invent symbols | **PASS** |
| `test_preservation_of_unchanged_fields` | Unaffected fields (intended purpose, UDI, IFU, etc.) preserved byte-for-byte | **PASS** |
| `test_prevention_of_invented_identifiers_and_product_facts` | Blank facts -> zero invented GTINs, serial numbers, contraindications, or addresses | **PASS** |
| `test_correct_version_diff_classification` | Exact classification into modified, unchanged, added; total fields sum consistency | **PASS** |
| `test_field_level_review_decisions` | Interactive updating of review decisions (Accepted, Needs revision, Rejected) | **PASS** |
| `test_json_serialization_and_provenance` | Roundtrip JSON serialization, deserialization, and Markdown diff export | **PASS** |
| `test_operation_without_optional_api_credentials` | Operates 100% deterministically with `OPENAI_API_KEY` removed | **PASS** |
| `test_udi_scenario_draft_generation` | UDI change scenario -> updates UDI-DI with 2D DataMatrix, preserves other fields | **PASS** |

**Full Suite Execution:**
- `pytest tests/ -v`: **59 passed in 3.26s** (100% pass rate, 0 failures, 0 regressions).

---

## 6. Demonstration Scenarios

### Scenario 1: Manufacturer Facility Relocation
- **Device:** CardioFlex Coronary Stent System (Class III Cardiovascular Implant)
- **Baseline Label:** Rev B (`data/label_authoring/sample_existing_label.json`)
- **Approved Facts:** Relocation to 450 Enterprise Boulevard, Boston, MA (`data/label_authoring/sample_approved_facts.json`)
- **Impact Assessment:** `data/change_impact/sample_change_request_impact_assessment.json`
- **Generated Draft:** Rev C (`data/label_authoring/proposed_label_draft.json`)
- **Outcome:** `manufacturer_info` and `instructions_for_use` contact block updated per 21 CFR 801.1; remaining 12 fields strictly preserved.

### Scenario 2: UDI-DI & Machine-Readable Carrier Update
- **Device:** OrthoSpine Pedicle Screw System (Class III Spinal Implant)
- **Baseline Label:** Rev C (`data/label_authoring/sample_existing_label_udi.json`)
- **Approved Facts:** New GTIN-14 `00812345678901` and 2D DataMatrix carrier (`data/label_authoring/sample_approved_facts_udi.json`)
- **Impact Assessment:** `data/change_impact/change_request_udi_impact_assessment.json`
- **Outcome:** `udi_identifiers` updated per 21 CFR 801.40 and FDA UDI guidance; manufacturer address and sterilization preserved.

---

## 7. Deliverables Summary

- `labelai_rag/label_models.py` — Label data models and diff reports
- `labelai_rag/label_authoring.py` — Grounded authoring and review engine
- `labelai_rag/streamlit_service.py` — Service integration and helpers
- `app.py` — Streamlit UI with dedicated 5th tab for Label Authoring & Review
- `data/label_authoring/sample_existing_label.json` — Sample existing approved label (CardioFlex)
- `data/label_authoring/sample_approved_facts.json` — Approved facts (Address change)
- `data/label_authoring/sample_existing_label_udi.json` — Sample existing approved label (OrthoSpine)
- `data/label_authoring/sample_approved_facts_udi.json` — Approved facts (UDI change)
- `data/label_authoring/proposed_label_draft.json` — Generated draft label produced by live service
- `data/label_authoring/version_diff_report.json` — Generated comparison report produced by live service
- `tests/test_label_authoring.py` — Automated test suite (11 targeted tests)
